Malignant epithelial tumor of salivary glands

Get in touch with RARE Concierge.

Contact RARE Concierge

A rare neoplastic disease characterized by the presence of a tumor located in the parotid sublingual submandibular and/or minor salivary glands which presents with a wide spectrum of clinical features depending on the location size and type of salivary gland involved ranging from clinically asymptomatic slow-growing painless mass(es) that may or may not be fixed to underlying skin or muscles to rapidly growing mass(es) associated with pain facial weakness/nerve palsy otorrhoea dysphagia palatal/parapharyngeal fullness nasal obstruction/bleeding voice hoarseness/change dyspnea trismus palate bone erosion telangiectasia mucosal/skin ulceration and/or cervical adenopathy.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview. Reference: Access aggregated data from Orphanet at Orphadata. Orphadata: Free access data from Orphanet. © INSERM 1999. Available on Data version June 2024

Newly diagnosed with
Malignant epithelial tumor of salivary glands?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

My Faulty Gene

My Faulty Gene is a nonprofit organization which provides information and assistance to any individual whose family medical history suggests genetic testing might be helpful in identifying an increased risk of disease due to a genetic mutation. We believe that everyone in need of genetic testing should have access to it.

My Little Sunshine Foundation

My Little Sunshine is a non-profit foundation dedicated to educating people about the importance of fertility preservation and making fertility resources accessible to all.


Educate and provide resources to POC with Rare Cancers

Don't see your organization here. Let us know here.

Clinical Trials

For a list of clinical trials in this disease area, please click here.